(R)-(-)-4-Phenyl-2-Oxazolidinone | CAS:90319-52-1

We serve (R)-(-)-4-Phenyl-2-Oxazolidinone CAS:90319-52-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(R)-(-)-4-Phenyl-2-Oxazolidinone

Chemical Name:(R)-(-)-4-Phenyl-2-Oxazolidinone
CAS.NO:90319-52-1
Synonyms:(R)-(-)-4-Phenyl-2-Oxazolidinone
(4R)-4-phenyl-1,3-oxazolidin-2-one
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 407.0±25.0 °C at 760 mmHg
Melting Point 131-133 °C(lit.)
Molecular Formula C9H9NO2
Molecular Weight 163.173
Flash Point 200.0±23.2 °C
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.548
 
Specification:
Appearance:Off-white crystalline powder
Assay(HPLC):≥99.0%
Single impurity:≤0.5%
Total impurities:≤1.0%
Chiral Assay(GC)≥99.5%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ezetimibe(CAS:163222-33-1).



Contact us for information like (R)-(-)-4-Phenyl-2-Oxazolidinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4R)-4-phenyl-1,3-oxazolidin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4R)-4-phenyl-1,3-oxazolidin-2-one Use and application,(R)-(-)-4-Phenyl-2-Oxazolidinone technical grade,usp/ep/jp grade.


Related News: Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.2-[2-(2-Methoxyphenoxy)ethyl]-1H-isoindole-1,3(2H)-dione manufacturer Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).4-Benzoylpyridine supplier Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).1-bromo-4-(4-bromo-3-methylphenyl)-2-methylbenzene vendor During the deadly SARS pandemic of the early 2000s, another traditional Chinese herbal medicine, Banlangen, made from the root of a flowering woad plant and used to treat the common cold, was sold out in many pharmacies due to a popular but clinically unproven belief that it could help prevent SARS, which is closely related to the Wuhan coronavirus.Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment.